Owner 3-Dimensional Pharmaceuticals, Inc.

Inventors Ballentine, Shelley K.; Pan, Wenxi; Ali, Farah; Leonard, Kristi; Gushue, Joan; Rudolph, M. Jonathan; Travins, Jeremy M.; Khalil, Ehab; Wall, Mark; Meegalla, Sanath; Huang, Hui; Hufnagel, Heather Rae; Subasinghe, Nalin; Wilson, Kenneth T.; Chen, Jinsheng; Cummings, Maxwell D.

Agent Callinan

Pub. Number AU-B-2003251384

PCT Number PCT/US03/16888

PCT Pub. Number WO2003/099805

Priority 60/383,130 28.05.02 US

Filing date 28 May 2003

Wipo publication date 12 December 2003

Acceptance publication date 29 January 2009

C07D 333/22 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4436 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4535 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 Drugs for disorders of the endocrine system